Clinical Trial Update: Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

Early-phase Phase 1 trial evaluating allogeneic B7H3 CAR-γδT cell therapy for advanced solid tumors and ovarian cancer; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Allogeneic B7H3 CAR-γδT Cell Therapy (B7H3 CAR-γδT cell therapy)

Snippet

Sponsor: Peking University | Conditions: Advanced Solid Tumors, Ovarian Cancers | EARLY_Phase 1 | Status: NOT_YET_RECRUITING